Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Clinical trial NCT00697632 · COMPLETED
Trial details
- NCT number
- NCT00697632
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2018-09-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.